These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

897 related items for PubMed ID: 9039301

  • 1. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L, Cutler TP, Helander I, Nyfors B, Downes N.
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [Abstract] [Full Text] [Related]

  • 2. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA, Abuzariba O, Rahim M, al-Taweel M, Abdulla SA.
    Int J Clin Pharmacol Res; 2000 Jan; 20(3-4):65-8. PubMed ID: 11314240
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
    Thawornchaisit P, Harncharoen K.
    J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
    [Abstract] [Full Text] [Related]

  • 4. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP, Van Erp PE, Van De Kerkhof PC.
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 6. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, Damstra R, Oranje AP, de Waard-van der Spek FB, van Neer P, Lijnen RL, Kunkeler AC, van Hees C, Haertlein NG, Hol CW.
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [Abstract] [Full Text] [Related]

  • 8. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, Andres P.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [Abstract] [Full Text] [Related]

  • 9. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G, Aldebani S, Elzorghany A, Benghazil M, Alhaddar J.
    Int J Clin Pharmacol Res; 2003 Apr; 23(2-3):47-51. PubMed ID: 15018018
    [Abstract] [Full Text] [Related]

  • 10. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L.
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [Abstract] [Full Text] [Related]

  • 11. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M, Mrowietz U, Koenig M, Simon JC.
    Eur J Dermatol; 2003 Jan; 13(3):261-5. PubMed ID: 12804986
    [Abstract] [Full Text] [Related]

  • 12. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A, Sommer A, Hyun J, Bräutigam M, Brockmeyer NH, Altmeyer P, Gambichler T.
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB, Perkins AC, Van Cott A, Kimball AB.
    Am J Clin Dermatol; 2010 Sep; 11(4):275-83. PubMed ID: 20513160
    [Abstract] [Full Text] [Related]

  • 14. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S.
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [Abstract] [Full Text] [Related]

  • 15. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L.
    Eur J Dermatol; 2010 Aug; 20(4):465-71. PubMed ID: 20413372
    [Abstract] [Full Text] [Related]

  • 16. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy.
    Kragballe K, Barnes L, Hamberg KJ, Hutchinson P, Murphy F, Møller S, Ruzicka T, Van De Kerkhof PC.
    Br J Dermatol; 1998 Oct; 139(4):649-54. PubMed ID: 9892908
    [Abstract] [Full Text] [Related]

  • 17. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, Oranje AP, de Rie MA, de Waard-van der Spek FB, Hol CW, van de Kerkhof PC.
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of calcipotriol ointment (50 micrograms/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis.
    Pinheiro N.
    Br J Clin Pract; 1997 Feb; 51(1):16-9. PubMed ID: 9158266
    [Abstract] [Full Text] [Related]

  • 19. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.
    Dermatology; 2008 Feb; 217(2):107-13. PubMed ID: 18463448
    [Abstract] [Full Text] [Related]

  • 20. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
    Saraceno R, Andreassi L, Ayala F, Bongiorno MR, Giannetti A, Lisi P, Martini P, Peris K, Peserico A, Chimenti S.
    J Dermatolog Treat; 2007 Feb; 18(6):361-5. PubMed ID: 17934937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.